We are sitting on a time bomb and the AMR Action Fund is one of the few player still investing in this space

ESCMID BBC movies

Thank you to people like Amanda Flores Bordoy for sharing their story during Limb Loss and Limb Difference Awareness Month, highlighting the danger of #sepsis , and exemplifying resilience. #LLLDAM #LLLDAM 2024 #AMR

In countries where lab-based surveillance methods are lacking, new research finds indirect predictors, including sociodemographic and healthcare indicators, could help decipher #AMR patterns. via CIDRAP cidrap.umn.edu/antimicrobial-…

A very interesting session at #ESCMIDGlobal titled “Antimicrobial resistance among displaced populations” by Dr. Souha Janj of American University of Beirut and Dr. Dmytro Stepanskyi of Dnipro, Ukraine, the latter citing AMR Action Fund CEO Henry Skinner.

A great discussion by Dr. Henry Skinner, CEO of the ⁦AMR Action Fund⁩ and Dr Matteo Bassetti after the showing of ⁦BBC StoryWorks⁩ “Race Against Resistance” at #GlobalESCMID

'Bringing pivmecillinam to the U.S. has the potential to benefit patients suffering from these harmful infections by giving clinicians a new, urgently needed treatment option for uncomplicated UTIs,' AMR Action Fund CEO Henry Skinner said, via CIDRAP cidrap.umn.edu/antimicrobial-…

Thanks to 日本医療政策機構 HGPI for hosting the Global Expert Meeting “Race Against Resistance - What Will Happen When Drug Resistance Spreads?” Panelists included: 塩崎やすひさ（塩崎恭久） Norio Ohmagari, Keiji Okinaka, Jun Sugihara, Takuko Sawada of SHIONOGI and Henry Skinner of AMR Action Fund

A nationwide analysis of US patients hospitalized with bloodstream infections caused by carbapenem-resistant Enterobacterales found that Black women had an increased risk of death compared with White women and Black men. #AMR cidrap.umn.edu/antimicrobial-… via CIDRAP

Congratulations to Utility Therapeutics who received approval for their penicillin class antibacterial, PIVYA, for the treatment of uncomplicated urinary tract infections (uUTIs). Learn more here: bit.ly/3UapQm9

“Uncomplicated UTIs are a very common condition impacting women and one of the most frequent reasons for antibiotic use,” said Peter Kim, director of the Division of Anti-Infectives in the FDA’s Center for Drug Evaluation and Research. “The FDA is committed to fostering new

Congratulations to our portfolio company Utility Therapeutics, which today received U.S. FDA approval of Pivya for uUTI, the first antibiotic approved in the US in ~20 years for this indication. Learn more: amractionfund.com/blog/amr-actio…

Looking forward to tomorrow's Union for International #CancerControl virtual dialogue, 'The crucial role of data in addressing AMR for better cancer care'—including an update from the Cancer & AMR Consortium—at 14:00 CEST/8 AM EST. Register! uicc.org/events/virtual… #AMR

'People are surviving these [drug-resistant] infections and they wear that internally. Our patient population wears that visibly,' said Ashlie White of Amputee Coalition during a panel discussion at British Embassy Washington. 'It can start with 'I got a cut on the back of my calf.'' #amr #LLLDAM

'By...addressing #AMR and cancer care we are not only safeguarding antimicrobials, but also ensuring cancer care remains effective in an era where AMR threatens to undo decades of medical progress.' -Shalini Jayasekar Zurn of Union for International #CancerControl

📢CDC Antimicrobial Resistance Exchange on #AMR and cancer care tomorrow from 10-11:30 AM ET! Registration info👇

A new Global Leaders Group on AMR report estimates that #AMR will drive down global life expectancy by 1.8 years and add $412 billion in health care costs by 2035. amrleaders.org/resources/m/it…